PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BME vs. FDUS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


BMEFDUS
YTD Return-1.45%7.21%
1Y Return-2.22%27.10%
3Y Return (Ann)-1.52%20.27%
5Y Return (Ann)6.82%17.43%
10Y Return (Ann)9.10%12.66%
Sharpe Ratio-0.152.00
Daily Std Dev11.78%13.97%
Max Drawdown-42.03%-69.51%
Current Drawdown-7.26%0.00%

Fundamentals


BMEFDUS
Market Cap$541.03M$627.26M
EPS$1.44$2.93
PE Ratio26.946.81
PEG Ratio0.003.59
Revenue (TTM)$8.19M$130.11M
Gross Profit (TTM)$7.73M$94.14M

Correlation

-0.50.00.51.00.2

The correlation between BME and FDUS is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

BME vs. FDUS - Performance Comparison

In the year-to-date period, BME achieves a -1.45% return, which is significantly lower than FDUS's 7.21% return. Over the past 10 years, BME has underperformed FDUS with an annualized return of 9.10%, while FDUS has yielded a comparatively higher 12.66% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
13.47%
24.27%
BME
FDUS

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BlackRock Health Sciences Trust

Fidus Investment Corporation

Risk-Adjusted Performance

BME vs. FDUS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust (BME) and Fidus Investment Corporation (FDUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BME
Sharpe ratio
The chart of Sharpe ratio for BME, currently valued at -0.15, compared to the broader market-2.00-1.000.001.002.003.004.00-0.15
Sortino ratio
The chart of Sortino ratio for BME, currently valued at -0.13, compared to the broader market-4.00-2.000.002.004.006.00-0.13
Omega ratio
The chart of Omega ratio for BME, currently valued at 0.98, compared to the broader market0.501.001.500.98
Calmar ratio
The chart of Calmar ratio for BME, currently valued at -0.10, compared to the broader market0.002.004.006.00-0.10
Martin ratio
The chart of Martin ratio for BME, currently valued at -0.31, compared to the broader market0.0010.0020.0030.00-0.31
FDUS
Sharpe ratio
The chart of Sharpe ratio for FDUS, currently valued at 2.00, compared to the broader market-2.00-1.000.001.002.003.004.002.00
Sortino ratio
The chart of Sortino ratio for FDUS, currently valued at 2.97, compared to the broader market-4.00-2.000.002.004.006.002.97
Omega ratio
The chart of Omega ratio for FDUS, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for FDUS, currently valued at 2.24, compared to the broader market0.002.004.006.002.24
Martin ratio
The chart of Martin ratio for FDUS, currently valued at 6.22, compared to the broader market0.0010.0020.0030.006.22

BME vs. FDUS - Sharpe Ratio Comparison

The current BME Sharpe Ratio is -0.15, which is lower than the FDUS Sharpe Ratio of 2.00. The chart below compares the 12-month rolling Sharpe Ratio of BME and FDUS.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00NovemberDecember2024FebruaryMarchApril
-0.15
2.00
BME
FDUS

Dividends

BME vs. FDUS - Dividend Comparison

BME's dividend yield for the trailing twelve months is around 6.54%, less than FDUS's 14.06% yield.


TTM20232022202120202019201820172016201520142013
BME
BlackRock Health Sciences Trust
6.54%6.32%5.87%5.03%5.04%5.65%6.58%6.58%9.32%17.04%9.83%9.85%
FDUS
Fidus Investment Corporation
14.06%14.63%10.51%8.90%10.15%8.17%13.69%10.54%10.17%11.66%11.51%8.92%

Drawdowns

BME vs. FDUS - Drawdown Comparison

The maximum BME drawdown since its inception was -42.03%, smaller than the maximum FDUS drawdown of -69.51%. Use the drawdown chart below to compare losses from any high point for BME and FDUS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-7.26%
0
BME
FDUS

Volatility

BME vs. FDUS - Volatility Comparison

BlackRock Health Sciences Trust (BME) has a higher volatility of 3.66% compared to Fidus Investment Corporation (FDUS) at 3.29%. This indicates that BME's price experiences larger fluctuations and is considered to be riskier than FDUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%NovemberDecember2024FebruaryMarchApril
3.66%
3.29%
BME
FDUS

Financials

BME vs. FDUS - Financials Comparison

This section allows you to compare key financial metrics between BlackRock Health Sciences Trust and Fidus Investment Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items